Dr. Sheldon E. Litwin, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 826
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: Washington University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
SC license 37313 -
Cardiovascular Disease Physician
SC license 37313 · UT license 264832-1205 -
Internal Medicine Physician
UT license 264832-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Musc Medical Center Charleston, SC
Medical groups
- University Medical Associates of the Medical University of South Carol (1,668 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 826
- Services billed
- 1,647
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 536 | 528 |
| Heart muscle strain imaging | 178 | 177 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 145 | 139 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 121 | 47 |
| Established patient office or other outpatient visit, 30-39 minutes | 121 | 104 |
| Ultrasound of heart blood flow, valves and chambers | 107 | 105 |
| Ultrasound of heart, follow-up | 96 | 82 |
| Ultrasound of heart with probe in esophagus, with report | 84 | 82 |
| 3d radiographic procedure | 63 | 62 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 48 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Charleston, SC | 250 |
| Jardiance (empagliflozin) Other prescribers in Charleston, SC | 162 |
| Furosemide Other prescribers in Charleston, SC | 103 |
| Metoprolol Succinate Other prescribers in Charleston, SC | 79 |
| Eliquis (apixaban) Other prescribers in Charleston, SC | 61 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Charleston, SC | 59 |
| Bumetanide Other prescribers in Charleston, SC | 58 |
| Atorvastatin Calcium Other prescribers in Charleston, SC | 58 |
| Losartan Potassium Other prescribers in Charleston, SC | 44 |
| Rosuvastatin Calcium Other prescribers in Charleston, SC | 43 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 5 payments worth $14,325 in total to this clinician.
| Novo Nordisk Inc | $14,234 |
|---|---|
| Edwards Lifesciences Corporation | $91.42 |
| Consulting Fee | $11,971 |
|---|---|
| Travel and Lodging | $1,574 |
| Compensation for services other than consulting (speaking, faculty) | $689 |
| Food and Beverage | $91.42 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Sep 26, 2025 | Consulting Fee Cardiovascular | $11,971 |
| Novo Nordisk Inc Sep 26, 2025 | Travel and Lodging Cardiovascular · travel to Minneapolis, MN · in-kind | $990 |
| Novo Nordisk Inc Sep 26, 2025 | Compensation for services other than consulting (speaking, faculty) Cardiovascular | $689 |
| Novo Nordisk Inc Sep 26, 2025 | Travel and Lodging Cardiovascular · travel to Minneapolis, MN · in-kind | $584 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $173,094 in research payments for these studies, mostly to the institutions running them.
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390 - A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Eli Lilly and Company · Completed · NCT04847557
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.